2019
DOI: 10.1097/aln.0000000000002624
|View full text |Cite
|
Sign up to set email alerts
|

Quality of Life and Lung Function in Survivors of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome

Abstract: Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New Background Survivors of acute respiratory distress syndrome (ARDS) have long-term impairment of pulmonary function and health-related quality of life, but little is known of outcomes of ARDS survivors treated with extracorporeal me… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
20
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(23 citation statements)
references
References 27 publications
2
20
1
Order By: Relevance
“…Comparison of the long-term outcomes of ARDS patients treated with ECMO and conventional ventilation strategies showed no signi cant difference in the 1-year survival but the non-ECMO group had greater impairment of health-related quality of life [30]. It has been suggested that the long-term functional limitation in ARDS survivors is not related to the degree of pulmonary dysfunction at admission, but rather to the consequences of invasive treatment at ICU and severity of illness [22,31].…”
Section: Discussionmentioning
confidence: 99%
“…Comparison of the long-term outcomes of ARDS patients treated with ECMO and conventional ventilation strategies showed no signi cant difference in the 1-year survival but the non-ECMO group had greater impairment of health-related quality of life [30]. It has been suggested that the long-term functional limitation in ARDS survivors is not related to the degree of pulmonary dysfunction at admission, but rather to the consequences of invasive treatment at ICU and severity of illness [22,31].…”
Section: Discussionmentioning
confidence: 99%
“…[ 19,20 ] ECMO is also known to be percutaneous cardiopulmonary bypass, emergency cardiopulmonary bypass, portable cardiopulmonary bypass, or percutaneous cardiopulmonary support. [ 21 ]…”
Section: Extracorporeal Membrane Oxygenationmentioning
confidence: 99%
“…In addition, in South Korea, the hospital survival rate among critically ill patients who underwent ECMO therapy due to respiratory failure has been improving in recent years [ 15 ]. Therefore, the quality of life (QOL) in ECMO survivors has emerged as an important public health issue [ 16 19 ]. One of the most important factors that might affect the worsening QOL in ECMO survivors is the decreased pulmonary function after discharge from the hospital.…”
Section: Introductionmentioning
confidence: 99%
“…Another retrospective study reported that 21 ECMO survivors from ARDS showed lung fibrosis, and minor pulmonary function abnormalities remained common at the 365-day follow-up period [ 17 ]. However, another prospective cohort study recently reported that pulmonary function was almost normal in 33 ECMO survivors from ARDS at the 365-day follow-up period [ 16 ]. Thus, the worsening QOL in ECMO survivors due to decreased pulmonary function remains controversial, and its impact on long-term mortality has not yet been clarified.…”
Section: Introductionmentioning
confidence: 99%